Xpedite Diagnostics products

The SwiftX™ cfDNA Extraction Kit is designed for efficient extraction of cell-free DNA (cfDNA) from large volumes of serum, plasma, and urine samples in under 15 minutes. This kit is particularly beneficial for applications in oncology research, prenatal testing, and infectious disease studies due to its rapid, sensitive, and accurate cfDNA extraction capabilities. Unlike traditional silica-based methods, the SwiftX™ cfDNA system does not require centrifugation or the use of dangerous chemicals and solvents, making it safer and more sustainable. It is compatible with various downstream analysis platforms, including qPCR, ddPCR, and NGS. Ideal for both standard lab environments and point-of-care settings, its protocol is adaptable to volumes ranging from 0.5mL to over 10mL. While the kit is intended for research use only, its precision and efficiency improve the workflow of laboratories engaged in cancer detection, prenatal screening like NIPT, and pathogen detection.

The SwiftX™ Blood Genomic kit offers a streamlined solution for rapid extraction of genomic DNA from whole blood samples, delivering results in under 15 minutes. Utilizing a unique reverse purification process where impurities bind to magnetic beads while nucleic acids remain free in the lysate, this technique ensures high yields of high-molecular weight DNA, suitable for applications like Nanopore sequencing. Compatible with real-time PCR, LAMP, and HLA and blood type testing, this method simplifies workflows in laboratories without compromising sensitivity and specificity. Designed to start from minimal blood volumes, it supports a range of applications including epigenetics, DNA profiling, cloning, and CRISPR-based gene editing. Its innovative approach allows researchers to enhance efficiency while minimizing environmental impact through reduced plastic use. Please note, it is intended for research use only and not for clinical diagnosis.

The SwiftX™ cfDNA extraction kit revolutionizes the process of isolating cell-free DNA from various bodily fluids such as serum, plasma, and urine in under 15 minutes. Designed to cater to the needs of researchers in oncology, prenatal testing, and infectious disease studies, SwiftX™ offers an efficient alternative to traditional silica-based methods. The extraction process eschews the requirements for complex steps like centrifugation, making it highly suitable for point-of-care diagnostics and applications in low-resource environments. Moreover, the method enhances workflow by supporting downstream analysis techniques including qPCR, ddPCR, and NGS without compromising accuracy. The kit contains ready-to-use reagents and does not necessitate harmful chemicals, offering an approach that reduces plastic use. With its high sensitivity and minimized false-positive rates, SwiftX™ cfDNA empowers laboratories to perform reliable and sustainable molecular testing.